These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 17259382)

  • 21. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
    Lai PB; Zhang L; Yang LY
    Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
    J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of C-peptide on early glomerular changes in diabetic mice.
    Maezawa Y; Yokote K; Sonezaki K; Fujimoto M; Kobayashi K; Kawamura H; Tokuyama T; Takemoto M; Ueda S; Kuwaki T; Mori S; Wahren J; Saito Y
    Diabetes Metab Res Rev; 2006; 22(4):313-22. PubMed ID: 16389646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Puberty permits increased expression of renal transforming growth factor-beta1 in experimental diabetes.
    Lane PH; Snelling DM; Hollman A; Langer WJ
    Pediatr Nephrol; 2001 Dec; 16(12):1033-9. PubMed ID: 11793095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
    Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
    Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
    Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis.
    Grygielko ET; Martin WM; Tweed C; Thornton P; Harling J; Brooks DP; Laping NJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):943-51. PubMed ID: 15769863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD36 is a novel and potential anti-fibrogenic target in albumin-induced renal proximal tubule fibrosis.
    Yang YL; Lin SH; Chuang LY; Guh JY; Liao TN; Lee TC; Chang WT; Chang FR; Hung MY; Chiang TA; Hung CY
    J Cell Biochem; 2007 Jun; 101(3):735-44. PubMed ID: 17226761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of the transforming growth factor beta1 by vitamin E in early nephropathy.
    Cojocel C; Al-Maghrebi M; Thomson MS; Rawoot P; Raghupathy R
    Med Princ Pract; 2005; 14(6):422-9. PubMed ID: 16220017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-beta-independent pathway.
    Lam S; van der Geest RN; Verhagen NA; Daha MR; van Kooten C
    Nephrol Dial Transplant; 2004 Jul; 19(7):1694-701. PubMed ID: 15150349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of transforming growth factor beta1 gene, basic fibroblast growth factor gene and hydroxyproline in diabetes-induced bladder dysfunction in a rat model.
    Yongzhi L; Benkang S; Jianping Z; Lingxia R; Wei B; Yaofeng Z; Keqin Z; Laudon V
    Neurourol Urodyn; 2008; 27(3):254-9. PubMed ID: 17763394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced albumin reabsorption in the proximal tubule of early-stage diabetic rats.
    Tojo A; Onozato ML; Ha H; Kurihara H; Sakai T; Goto A; Fujita T; Endou H
    Histochem Cell Biol; 2001 Sep; 116(3):269-76. PubMed ID: 11685557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats.
    Paczek L; Gaciong Z; Bartlomiejczyk I; Sebekova K; Birkenmeier G; Heidland A
    Drugs Exp Clin Res; 2001; 27(4):141-9. PubMed ID: 11822224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulated IL-18 expression in type 2 diabetic subjects with nephropathy: TGF-beta1 enhanced IL-18 expression in human renal proximal tubular epithelial cells.
    Miyauchi K; Takiyama Y; Honjyo J; Tateno M; Haneda M
    Diabetes Res Clin Pract; 2009 Feb; 83(2):190-9. PubMed ID: 19110334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic potential of angiostatin in diabetic nephropathy.
    Zhang SX; Wang JJ; Lu K; Mott R; Longeras R; Ma JX
    J Am Soc Nephrol; 2006 Feb; 17(2):475-86. PubMed ID: 16394111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-hexacosanol ameliorates streptozotocin-induced diabetic rat nephropathy.
    Saito M; Kinoshita Y; Satoh I; Shinbori C; Kono T; Hanada T; Uemasu J; Suzuki H; Yamada M; Satoh K
    Eur J Pharmacol; 2006 Aug; 544(1-3):132-7. PubMed ID: 16859672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperlipidemia induced by high fat diet ingestion activates TGF-beta/Smad signaling pathway in the kidney of diabetic rats].
    Chen ZX; Xie XY; Yu RC; Zhang J; Lei MX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):906-12. PubMed ID: 19001732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
    Hamada Y; Fukagawa M
    Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.